Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2026-03-20 @ 6:24 AM
Study NCT ID:
NCT02864394
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2016-08-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Pembrolizumab Versus Docetaxel in Participants Previously Treated for Non-Small Cell Lung Cancer (MK-3475-033/KEYNOTE-033)
Sponsor:
Organization: